Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000008

CFO AND TREASURER sold 21,000 shares at an average $479.99 ($10,079,696)

  • CFO AND TREASURER acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-01 Exercise or conversion : show line 1 in the form 10b5-1 +21,000 $146.03 $3,066,630 29,142 D
2025-12-01 Sale : show line 2 in the form 10b5-1 −2,853 $477.98 $1,363,672 26,289 D
2025-12-01 Sale : show line 3 in the form 10b5-1 −4,198 $479.11 $2,011,284 22,091 D
2025-12-01 Sale : show line 4 in the form 10b5-1 −7,552 $479.92 $3,624,368 14,539 D
2025-12-01 Sale : show line 5 in the form 10b5-1 −3,858 $480.95 $1,855,492 10,681 D
2025-12-01 Sale : show line 6 in the form 10b5-1 −1,476 $481.80 $711,143 9,205 D
2025-12-01 Sale : show line 7 in the form 10b5-1 −903 $483.04 $436,188 8,302 D
2025-12-01 Sale : show line 8 in the form 10b5-1 −160 $484.68 $77,549 8,142 D
Open-market sales · 21,000 sh · avg $479.99 · $10,079,696

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-12-01 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option −517 $146.03 2027-03-15 517 0 D
2025-12-01 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −20,483 $146.03 2027-03-15 20,483 24,517 D
Loading xslF345X05/primarydocument.xml…